Survival of Dental Implants in Bisphosphonate Users Versus Non-Users: A Systematic Review

被引：6

作者：

Kumar, M. N. ^{[1
]}

Honne, T. ^{[1
]}

机构：

[1] JSS Dent Coll & Hosp, Dept Prosthodont, Mysore 570015, Karnataka, India

来源：

EUROPEAN JOURNAL OF PROSTHODONTICS AND RESTORATIVE DENTISTRY | 2012年 / 20卷 / 04期

关键词：

Bisphosphonates; Dental implants; Osteonecrosis;

D O I：

10.1922/EJPRD_1142Kumar04

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

To investigate the literature regarding the survival rate of dental implants in bisphosphonate users as compared to non-users. An online search of literatures through MEDLINE-PUBMED (1950-March 2012), Cochrane Database of Systematic reviews, the Cochrane Central Register of Controlled Trials (CENTRAL) (1800-March 2012) and EMBASE (1966-March 2012) databases was performed. All the relevant publications were identified and full texts of these articles were obtained. After scrutinizing the relevant articles and their related references five articles that fulfilled the inclusion criteria were finalized. Only one study stated that dental implant failure was higher in patients under bisphosphonate therapy. The implant survival rates ranged between 95% and 100% in case of bisphosphonate users and 96.5% to 99.2% in non-users. Within the limitations of this review, it can be concluded that short term bisphosphonate therapy does not increase or decrease the survival rate of dental implants in bisphosphonate users as compared to non-users.

引用

页码：159 / 162

页数：4

共 34 条

[1] American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws [J].

不详 .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2007, 65 (03) :369-376

[2] Aging of microstructural compartments in human compact bone [J].

Akkus, O ;

Polyakova-Akkus, A ;

Adar, F ;

Schaffler, MB .

JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (06) :1012-1019

[3] Collagen telopeptide (serum CTX) and its relationship with the size and number of lesions in osteonecrosis of the jaws in cancer patients on intravenous bisphosphonates [J].

Bagan, Jose V. ;

Jimenez, Yolanda ;

Gomez, Dolores ;

Sirera, Rafael ;

Poveda, Rafael ;

Scully, Crispian .

ORAL ONCOLOGY, 2008, 44 (11) :1088-1089

[4] Jaw osteonecrosis associated with bisphosphonates:: Multiple exposed areas and its relationship to teeth extractions.: Study of 20 cases [J].

Bagan, JV ;

Jimenez, Y ;

Murillo, J ;

Hernandez, S ;

Poveda, R ;

Sanchis, JM ;

Díaz, JM ;

Scully, C .

ORAL ONCOLOGY, 2006, 42 (03) :327-329

[5] Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases [J].

Bagan, JV ;

Murillo, J ;

Jimenez, Y ;

Poveda, R ;

Milian, MA ;

Sanchis, JM ;

Silvestre, FJ ;

Scully, C .

JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2005, 34 (02) :120-123

[6] Oral Bisphosphonates and dental implants: A retrospective study [J].

Bell, Brian M. ;

Bell, Robert Edward .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2008, 66 (05) :1022-1024

[7]

Chen N, 2002, CANCER RES, V62, P6538

[8] Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females [J].

Ciarelli, TE ;

Fyhrie, DP ;

Parfitt, AM .

BONE, 2003, 32 (03) :311-315

[9]

Fleisch H, 2002, BREAST CANCER RES, V4, P30, DOI 10.1186/bcr414

[10] Clodronate and liposome-encapsulated clodronate are metabolized to a toxic ATP analog, adenosine 5'-(beta,gamma-dichloromethylene) triphosphate, by mammalian cells in vitro [J].

Frith, JC ;

Monkkonen, J ;

Blackburn, GM ;

Russell, RGG ;

Rogers, MJ .

JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (09) :1358-1367

← 1 2 3 4 →